ConductScience.org, home

Paper75851

Inhibition of allergic reactions by cromoglycate and by a new anti-allergy drug U-42,585E. I. Activity in rats.

Johnson HG and 2 others. Int Arch Allergy Appl Immunol, 1978. Cited by 47 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Inhibition of allergic reactions by cromoglycate and by a new anti-allergy drug U-42,585E. I. Activity in rats. Papers, record 75851. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/75851

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inhibition of allergic reactions by cromoglycate and by a new anti-allergy drug U-42,585E. I. Activity in rats.
PubMed
Journal
Int Arch Allergy Appl Immunol
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
47
iCite
Relative citation ratio, by iCite
2.75
iCite
Revised in PubMed
2019-12-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Johnson HGH G
2VanHout CAC A
3Wright JBJ B

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Amino AcidsMajor topic
Cromolyn SodiumMajor topic
Histamine ReleaseMajor topic
Oxamic AcidMajor topic
Passive Cutaneous AnaphylaxisMajor topic
Administration, Oral
Animals
Dose-Response Relationship, Drug
Dose-Response Relationship, Immunologic
Female
Injections, Intravenous
Nitriles
Rats
Tromethamine

Source PubMed

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.

PMIDTitleJournalYearIn PapersSource
26,063,046Salt formation during freeze-drying--an approach to enhance indomethacin dissolution.Pharm Res2015https://conductscience.org/library/papers/26063046PubMed
11,349,610Ocular allergy treatments.Clin Rev Allergy Immunol2001https://conductscience.org/library/papers/11349610PubMed
7,582,525A role for mast cells in adenosine A3 receptor-mediated hypotension in the rat.Br J Pharmacol1995https://conductscience.org/library/papers/7582525PubMed
6,169,263In vitro studies on the mechanism of action of a new antiallergic, Ro 21-7634.Agents Actions1981https://conductscience.org/library/papers/6169263PubMed
6,136,101Inhalation challenge with specific grass pollen antigens in asthmatics and the effect of lodoxamide tromethamine.Thorax1983https://conductscience.org/library/papers/6136101PubMed
6,121,476Inhibition of oxidative enzymes by anti-allergy drugs.Agents Actions1981https://conductscience.org/library/papers/6121476PubMed
2,875,630The characterization of lodoxamide, a very active inhibitor of mediator release, in animal and human models of asthma.Agents Actions1986https://conductscience.org/library/papers/2875630PubMed
2,435,353Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol.Br J Pharmacol1987https://conductscience.org/library/papers/2435353PubMed
115,253The effect of lodoxamide ethyl [diethyl N,N'-(2-chloro-5-cyano-m-phenylene)dioxamate] on in vivo anaphylactic reactions.Agents Actions1979https://conductscience.org/library/papers/115253PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/75851

GET https://conductscience.org/api/papers/v1/75851/authors